JP2013542960A5 - - Google Patents

Download PDF

Info

Publication number
JP2013542960A5
JP2013542960A5 JP2013537904A JP2013537904A JP2013542960A5 JP 2013542960 A5 JP2013542960 A5 JP 2013542960A5 JP 2013537904 A JP2013537904 A JP 2013537904A JP 2013537904 A JP2013537904 A JP 2013537904A JP 2013542960 A5 JP2013542960 A5 JP 2013542960A5
Authority
JP
Japan
Prior art keywords
phenyl
sulfonyl
diazaspiro
oxa
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013537904A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013542960A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/059563 external-priority patent/WO2012064642A1/en
Publication of JP2013542960A publication Critical patent/JP2013542960A/ja
Publication of JP2013542960A5 publication Critical patent/JP2013542960A5/ja
Pending legal-status Critical Current

Links

JP2013537904A 2010-11-08 2011-11-07 脂肪酸シンターゼ阻害剤 Pending JP2013542960A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41111010P 2010-11-08 2010-11-08
US61/411,110 2010-11-08
PCT/US2011/059563 WO2012064642A1 (en) 2010-11-08 2011-11-07 Fatty acid synthase inhibitors

Publications (2)

Publication Number Publication Date
JP2013542960A JP2013542960A (ja) 2013-11-28
JP2013542960A5 true JP2013542960A5 (enExample) 2014-10-23

Family

ID=46051253

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013537904A Pending JP2013542960A (ja) 2010-11-08 2011-11-07 脂肪酸シンターゼ阻害剤

Country Status (4)

Country Link
US (1) US20130237535A1 (enExample)
EP (1) EP2637660A4 (enExample)
JP (1) JP2013542960A (enExample)
WO (1) WO2012064642A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2744333B1 (en) * 2011-08-19 2016-10-05 Glaxosmithkline Intellectual Property (No. 2) Limited Fatty acid synthase inhibitors
WO2013177253A2 (en) * 2012-05-22 2013-11-28 Glaxosmithkline Llc Fatty acid synthase inhibitors
AR092211A1 (es) 2012-09-24 2015-04-08 Merck Patent Ges Mit Beschränkter Haftung Derivados de hidropirrolopirrol
ES2651331T3 (es) 2013-01-10 2018-01-25 Glaxosmithkline Intellectual Property (No. 2) Limited Inhibidores de la sintasa de ácidos grasos
KR102194745B1 (ko) 2013-03-13 2020-12-24 포르마 세라퓨틱스 인크. Fasn 억제용 신규 화합물 및 조성물
ES2821049T3 (es) 2015-06-18 2021-04-23 89Bio Ltd Derivados de piperidina 1,4 sustituidos
MX379846B (es) 2015-06-18 2025-03-11 89Bio Ltd Derivados de 4-bencil y 4-benzoil piperidina sustituidos.
JOP20190053A1 (ar) 2016-09-23 2019-03-21 Novartis Ag مركبات أزا إندازول للاستخدام في إصابات الأوتار و/ أو الرباط
CA3033249A1 (en) 2016-09-23 2018-03-29 Novartis Ag Indazole compounds for use in tendon and/or ligament injuries
CN107628968B (zh) * 2017-10-10 2019-09-06 北京汇康博源医药科技有限公司 一种简便合成1-氨基-1-腈基-环丙烷的方法
WO2019228829A1 (en) 2018-05-30 2019-12-05 Robert Bosch Gmbh Battery including bipolar cells that have an edge insulating device supported by a support frame
TWI767148B (zh) 2018-10-10 2022-06-11 美商弗瑪治療公司 抑制脂肪酸合成酶(fasn)
EP3873214A4 (en) 2018-10-29 2022-07-13 Forma Therapeutics, Inc. Solid forms of (4-(2-fluoro-4-(1-methyl-1 h-benzo[d]imidazol-5-yl)benzoyl) piperazin-1-yl)(1-hydroxycyclopropyl)methanone
AU2020334069A1 (en) * 2019-08-22 2022-03-24 The Regents Of The University Of Michigan Method of treating KRAS-associated cancers
CN111574414A (zh) * 2020-05-20 2020-08-25 上海毕得医药科技有限公司 一种4-溴-2-甲氧基苯磺酰氯的合成方法
EP4457227A4 (en) * 2021-12-27 2025-12-03 Astellas Pharma Inc QUINOLEIN DERIVATIVE SUBSTITUTE
CN116478158A (zh) * 2023-04-26 2023-07-25 湖南警察学院 一种制备螺环化合物的方法
US20250375429A1 (en) 2024-05-29 2025-12-11 Smarter Not Harder, Inc. Obligate pairing of orthosteric and non-orthosteric gaba ligands in pharmaceutical formulations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997011940A1 (en) * 1995-09-29 1997-04-03 Eli Lilly And Company Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation
CO5180605A1 (es) * 1999-06-23 2002-07-30 Smithkline Beecham Corp Compuestos de indol
CA2389034A1 (en) * 1999-10-27 2001-05-03 Cor Therapeutics, Inc. Pyridyl-containing spirocyclic compounds as inhibitors of fibrinogen-dependent platelet aggregation
US7498323B2 (en) * 2003-04-18 2009-03-03 Ono Pharmaceuticals Co., Ltd. Spiro-piperidine compounds and medicinal use thereof
WO2006006490A1 (ja) * 2004-07-08 2006-01-19 Ono Pharmaceutical Co., Ltd. スピロ化合物
TW200831092A (en) * 2006-12-21 2008-08-01 Astrazeneca Ab Therapeutic agents
WO2008088692A2 (en) * 2007-01-12 2008-07-24 Merck & Co., Inc. Spirochromanon derivatives
CA2703138A1 (en) * 2007-10-26 2009-04-30 F. Hoffmann-La Roche Ag Purine derivatives useful as pi3 kinase inhibitors
US8450350B2 (en) * 2010-05-05 2013-05-28 Infinity Pharmaceuticals, Inc. Triazoles as inhibitors of fatty acid synthase

Similar Documents

Publication Publication Date Title
JP2013542960A5 (enExample)
JP2012512888A5 (enExample)
US9024033B2 (en) Anti-malarial agents
JP5345140B2 (ja) プロトンポンプ阻害剤としての5員複素環化合物
JP2007509141A5 (enExample)
CA2459224C (en) 1,3-benzothiazinone derivatives and the use thereof
JP2013507425A5 (enExample)
JP2012532931A5 (enExample)
RU2006125720A (ru) Пиперидинаминобензимидазольные производные как ингибиторы репликации респираторного синцитиального вируса
JP2010524942A5 (enExample)
ES2361933T3 (es) Uso de derivados de azabiciclo hexano.
RU2012126083A (ru) Производные аминооксазина
JP2016525076A5 (enExample)
ME02104B (me) Inhibitori kinaza koji regulisu signalne puteve u apoptozi
RU2015148926A (ru) Аза-оксо-индолы для лечения и профилактики респираторно-синцитиальной вирусной инфекции
AU2011346567A1 (en) Bi-heteroaryl compounds as Vps34 inhibitors
JP2014520885A5 (enExample)
WO2008034008A2 (en) Kinase inhibitors useful for the treatment of proliferative diseases
JP2013534245A5 (enExample)
RU2013134334A (ru) Хиноксалины и азахиноксалины в качестве модуляторов рецептора crth2
CA2829131A1 (en) Amino-quinolines as kinase inhibitors
WO2012064642A1 (en) Fatty acid synthase inhibitors
CA2966303A1 (en) Substituted pyridines as bromodomain inhibitors
JP2017501237A5 (enExample)
CN114748622A (zh) P38激酶抑制剂降低dux4和下游基因表达以用于治疗fshd